Jump Financial’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
DM
SCM
HA
KCM
Jump Financial's LEGN Position: Q2 2026 in Review
Jump Financial sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 516,633 shares — an estimated $9.35M sold.
Jump Financial first reported a position in LEGN in Q2 2021 and held it in 17 quarters. The position peaked at $13.1M in Q3 2025. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.
- Jump Financial reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
- Jump Financial sold 516,633 Legend Biotech shares in Q2 2026, an estimated $9.35M.
- Jump Financial first reported a position in Legend Biotech in Q2 2021 and held it in 17 quarters.
- Jump Financial's Legend Biotech position peaked at $13.1M in Q3 2025.
- 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.